Animal-Free Fusion Casein Production via Recombinant Host Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The growing demand for milk and dairy products poses environmental and health concerns due to the unsustainable nature of animal agriculture, including high greenhouse gas emissions, antibiotic resistance, and lactose intolerance, necessitating a sustainable and humane alternative for bovine milk proteins.
Innovation Solution
The development of animal-free fusion milk proteins produced in recombinant host cells using genetic engineering, which mimics naturally occurring milk proteins, reducing environmental impact and providing a safe, nutritious alternative.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If animal agriculture is used to meet growing demand for milk and dairy products, then protein supply increases, but greenhouse gas emissions and environmental impact worsen
Solution Approach 1:
The patent creates synthetic milk proteins that copy the structure and function of natural bovine milk proteins (alpha S1-casein and alpha S2-casein) using recombinant DNA technology. The synthetic proteins are designed to mimic the amino acid sequences and functional properties of natural caseins, providing the same nutritional and technological benefits without requiring animal agriculture. This copying approach allows production of milk proteins in controlled bioreactors using microorganisms or cell cultures, eliminating the greenhouse gas emissions associated with cattle farming while maintaining protein supply.
2Reliability
If antibiotics are administered to prevent illness in animals, then animal health improves, but antibiotic resistance develops
Solution Approach 1:
The patent extracts the essential function of animal agriculture (production of milk proteins) and separates it from the harmful practice of antibiotic administration. By producing milk proteins synthetically in controlled bioreactor systems using genetically engineered microorganisms or cell cultures, the need for antibiotics is completely eliminated. The synthetic production system provides a reliable source of milk proteins without any exposure to antibiotics, thereby preventing antibiotic resistance while maintaining the ability to produce high-quality protein products.
3Quantity of substance
If natural cow milk is consumed, then nutritional needs are met, but lactose intolerance issues arise
Solution Approach 1:
The patent copies only the beneficial components of natural milk (the casein proteins) while excluding the harmful component (lactose). The synthetic milk proteins are produced as pure protein products without any lactose or other mammalian-derived components. This selective copying allows individuals with lactose intolerance to consume milk protein products that provide the same nutritional benefits as natural milk without triggering digestive issues. The synthetic proteins maintain the functional properties of natural caseins for nutrition and food processing applications.
4Quantity of substance
If animal farming is expanded to meet population growth, then food security improves, but land and water resources are depleted
Solution Approach 1:
The patent replaces the mechanical/biological system of animal farming with a biotechnological production system. Instead of raising cattle that require extensive land for grazing and feed production, along with significant water consumption, the invention uses controlled bioreactor systems with genetically engineered microorganisms or cell cultures. This substitution dramatically reduces the land and water footprint while maintaining or increasing protein production capacity. The synthetic milk proteins can be produced in compact facilities using recycled water and minimal land, addressing food security concerns without depleting natural resources.
Data Source
AI summary
The present invention broadly relates to the field of biotechnology. More particularly, the present invention relates to animal-free fusion milk proteins and a process for the production of the same in recombinant host cells. Also, the present invention provides vectors, and expression cassettes for the expression of animal-free milk proteins in host cells.